Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations
   

EFPIA Newsletter 5 December 2024

 
 
 
   

Resetting Europe’s Innovation Compass

 
Read the full article here.

Europe’s pharmaceutical sector has grown slowly for 25 years and its share of research is shrinking. It’s time to turn things around.

 

The EFPIA’s recently published European Economic Impact report shows that research and development (R&D) expenditure in Europe has grown on average by 4.4 percent each year between 2010 and 2022, from €27.8 billion to €46.2 billion.

Good news? Yes and no. If we look at the wider picture, Europe’s position is clearly becoming more and more precarious against a backdrop of falling competitiveness. While global research into medicines and vaccines is growing, Europe’s share of the pie is getting smaller as the distribution of R&D shifts elsewhere.

 

Read more


 
 
 
   

News

 
Thumbnail

Pharmaceutical innovators are concerned over not enough advice meetings being offered in 2025...
05 December 2024

From 12 January 2025 the EU HTA Regulation will apply and the first JCAs will be performed to assess the relative clinical... Read more

Thumbnail

9 ways to maximise the impact of the future EU Framework Programme for Research and Innovation...
05 December 2024

Ahead of the discussions on the EU future Framework Programme for Research and Innovation (FP10), EFPIA is putting forward... Read more

Thumbnail

EFPIA response to EPSCO meeting
03 December 2024

Today’s EPSCO meeting covered a number of health files. EFPIA particularly welcomes the adoption of council conclusions... Read more

 
 
 
   

The EFPIA Conference is only a few days away!

Join leaders from the pharmaceutical industry, policymakers, patient advocates, and healthcare experts to discuss how we can work together to build a healthier, more competitive Europe.

Discover the programme and register here.

 
 
 
 
   

EU Health Summit 2025: Reshaping health for a stronger Europe

Keeping the health sector high on the political agenda is essential for the well-being of Europeans, a resilient workforce, the growth of the EU economy, and the security of Europe. This is why, during this EU mandate, we need a robust and integrated strategy for health policy.

Join the EU Health Summit on 28 January to help shape a roadmap for a healthier Europe.


 
 
 
 
   

Call to Action - 5 Ways to Reduce Cancer Care Inequalities in Europe

Cancer Patients Europe calls for the new EU mandate to build on the momentum garnered by the launch of Europe’s Beating Cancer Plan to ensure that all aspects of the cancer pathway, from prevention and early diagnosis, diagnostics and treatments to survivorship, remain at the forefront of political agendas.

Learn more about the call to action here.